Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

112.21
Delayed Data
As of Jan 19
 -1.06 / -0.94%
Today’s Change
67.81
Today|||52-Week Range
132.95
-0.42%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close113.27
Today’s open113.47
Day’s range111.62 - 113.64
Volume387,372
Average volume (3 months)498,134
Market cap$4.9B
Dividend yield--
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+33.18%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio115.7
Price/Sales12.92
Price/Book12.96

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.63-0.75%
MASIMasimo Corp-0.40-0.55%
NUVANuVasive Inc-0.23-0.33%
CMDCantel Medical Corp+0.62+0.81%
Data as of 01/19/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs